Michael Petusky

Stock Analyst at Barrington Research

(2.28)
# 2,757
Out of 5,055 analysts
220
Total ratings
42.13%
Success rate
-2.38%
Average return

Stocks Rated by Michael Petusky

Merit Medical Systems
Nov 14, 2025
Maintains: Outperform
Price Target: $106
Current: $85.09
Upside: +24.57%
Surmodics
Nov 14, 2025
Downgrades: Underperform
Price Target: n/a
Current: $41.61
Upside: -
DENTSPLY SIRONA
Nov 10, 2025
Maintains: Outperform
Price Target: $18$14
Current: $10.52
Upside: +33.08%
Haemonetics
Nov 7, 2025
Maintains: Outperform
Price Target: $86$90
Current: $73.49
Upside: +22.47%
Anika Therapeutics
Nov 6, 2025
Maintains: Outperform
Price Target: $15$16
Current: $9.99
Upside: +60.16%
Henry Schein
Nov 5, 2025
Maintains: Outperform
Price Target: $78$79
Current: $71.42
Upside: +10.61%
Orthofix Medical
Nov 5, 2025
Maintains: Outperform
Price Target: $17$18
Current: $14.96
Upside: +20.32%
Option Care Health
Oct 31, 2025
Maintains: Outperform
Price Target: $38
Current: $28.41
Upside: +33.76%
OPKO Health
Oct 30, 2025
Maintains: Outperform
Price Target: $2.25
Current: $1.28
Upside: +75.78%
U.S. Physical Therapy
Oct 24, 2025
Maintains: Outperform
Price Target: $103
Current: $71.67
Upside: +43.71%
Maintains: Outperform
Price Target: $95
Current: $88.44
Upside: +7.42%
Maintains: Outperform
Price Target: $1.25$1.5
Current: $0.80
Upside: +87.73%
Downgrades: Market Perform
Price Target: n/a
Current: $7.96
Upside: -